Pfizer Profile

USD 0.79  1.84%

Pfizer exotic insider transaction detected

Pfizer insider trading alert for general transaction of stock appreciation rights by Anthony Maddaluna, Executive Vice President, on October 15, 2018. This event was filed by the entity with SEC on 2013-01-09. Initial filing of beneficial ownership - SEC Form 3. Anthony Maddaluna is currently serves as executive vice president and presidentident - pfizer global supply of Pfizer [view details]   

Pfizer Summary

Pfizer is a pharmaceutical company in the United States and is among one of the largest. Big pharma is what it is typically called here in the U.S. and is looked at in many different lights. [more]
Pfizer (PFE) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 90,200 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 266.61 B. Pfizer runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 5.86 B outstanding shares of which 50.59 M shares are at this time shorted by investors with about 2.73 days to cover shorted positions. PFIZER INC has about 13.49 B in cash with 14.59 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3.
Check Pfizer Probability Of Bankruptcy

Ownership Allocation (%)

Pfizer Target Price Odds Analysis

Odds Below 43.78HorizonTargetOdds Above 43.78
42.71%30 days 43.78 56.68%
Based on normal probability distribution, the odds of Pfizer to move above current price in 30 days from now is about 56.68% (This Pfizer probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 30 days) .

Pfizer Top Holders

Pfizer Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Pfizer Key Fundamentals

Pfizer Against Markets

Pfizer Current Ratings

Pfizer 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Pfizer are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 90200 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Pfizer SEC Filings
Pfizer SEC Filings
Security & Exchange Commission EDGAR ReportsView All
ChairmanIan ReadView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
LocationNEW YORK U.S.A
Business Address235 East 42nd Street
Foreign Associates
ExchangeBATS Exchange
CIK Number0000078003
IndustryDrug Manufacturers - Major
Phone212 733 2323
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJuly 1, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestSeptember 14, 2018

Did you try this?

Run Companies Directory Now


Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Companies Directory

Pfizer Directors

Pfizer Corporate Directors

Helen Hobbs Independent Director
Shantanu Narayen Director
James Smith Director
Additionally take a look at Your Equity Center. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.